This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Ignacio Marcos Larrayoz: Innovator in Pharmaceutical Treatments
Introduction
Ignacio Marcos Larrayoz is a notable inventor based in Sarriguren, Spain. He has made significant contributions to the field of pharmaceutical treatments, particularly in addressing inflammation-related conditions. His innovative work has led to the development of a patent that showcases his expertise and dedication to improving health outcomes.
Latest Patents
Ignacio holds a patent for "Methods of treatment using sterculic acid." This patent describes the use of sterculic acid, along with its pharmaceutically acceptable salt forms, for the treatment of inflammation. Specifically, it targets 7-ketocholesterol induced inflammation, 7-ketocholesterol toxicity, and unregulated angiogenesis. This innovative approach has the potential to provide new therapeutic options for patients suffering from these conditions.
Career Highlights
Ignacio is associated with the United States of America, as represented by the Secretary, Department of Health and Human Services. His work in this capacity has allowed him to contribute to important health initiatives and research projects. With a focus on pharmaceutical advancements, he continues to push the boundaries of medical science.
Collaborations
Ignacio has collaborated with esteemed colleagues, including Ignacio R Rodriguez and Jiahn-Dar Huang. These partnerships have fostered a collaborative environment that enhances the research and development of innovative treatments.
Conclusion
Ignacio Marcos Larrayoz is a distinguished inventor whose work in pharmaceutical treatments is making a significant impact in the field of medicine. His patent on sterculic acid demonstrates his commitment to addressing critical health issues. Through his career and collaborations, he continues to contribute to advancements in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
